Purchase Order 75N98026P01060
Award Date 7/20/26
Potential Completion Date 1/20/27
Potential Value $400K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Newark, CA 94560, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Advanced Cell Diagnostics, Inc. valued at $11,593.00 on May 28, 2021, for RNAscope technology and related reagents. Work is performed in Newark, California. The purchase order, issued under firm fixed-price terms with no set-aside, provides RNA detection and visualization capabilities for identifying TGF-beta isoforms in normal tissues and tumors using minimal sample material. The order closes on June 27, 2021.</p>
- The National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $26,857 firm-fixed-price purchase order contract to Advanced Cell Diagnostics, Inc. (ACD) for the procurement of RNAscope In-House Assay or equivalent technology. This contract was awarded on July 21, 2025, with a completion date of September 25, 2025. ACD is a for-profit molecular diagnostics company specializing in advanced RNA detection technologies, including the RNAscope platform....
- The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for $116,928.00 on June 22, 2026, to supply Infinium Methylation Screening Array-48 kits for an epigenome-wide association study of cardiovascular disease mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Work is performed in San Diego, California. The order carries a firm fixed-price structure with an ultimate completion date of June 21, 2027. No set-aside designation applies.
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $16,580 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for RNAScope under contract number 1187802. Advanced Cell Diagnostics, Inc. will deliver its cell diagnostics technology from its Newark, California location under the eight-month contract ending in March 2024. As part of the National Institutes of Health's medical research efforts, this contract provides RNAScope, a...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Mission Bio, Inc. for $49,900 on January 24, 2020, for acquisition of a Missionbio single-cell multi-omics platform for an AML lab. Performance takes place in South San Francisco, California. The order is firm fixed price with an ultimate completion date of February 23, 2020.</p>
- The National Heart Lung and Blood Institute issued a $106,101.30 delivery order to Illumina, Inc. on September 2, 2026, for next-generation sequencing kits and reagents to support the NHLBI Sequencing Core Facility. Place of performance is San Diego, California. The order is firm fixed price with an ultimate completion date of September 2, 2026. The delivery order procures Illumina sequencing kits and reagents required to conduct next-generation sequencing on Illumina instruments for supported...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to 10X Genomics, Inc. for $43,337.50 for single-cell RNA-seq technology on February 10, 2021, with a total small business set-aside designation and performance completion by March 12, 2021. Work is performed in Pleasanton, California. The order is for firm fixed price supply of single-cell genomic analysis platforms, reagents, and related consumables supporting biomedical research.</p>
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The $120.00 contract is for the procurement of AMBIS 1770629 RNAscope H202 & Protease Plus Reagents, a product used to support biomedical research efforts across various NIH institutes and other federal...
- Advanced Cell Diagnostics, Inc. has been awarded an $11,183.20 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNAscope assay biological products including kits, reagents and probes. As a leader in molecular pathology, Advanced Cell Diagnostics will supply its proprietary RNAScope platform and accompanying products to support the federal research programs of the Department of Health and Human Services agency....
- <p>The National Heart Lung and Blood Institute issued an $82,024.32 delivery order to Illumina, Inc. on August 6, 2020, for Illumina sequencing kits and reagents supporting next-generation sequencing on Illumina instruments at the NHLBI Sequencing Core Facility.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of September 2, 2020.</p>